Immunoglobulin National Society Holds 15th Annual Conference in Las Vegas
Industry leaders in immunoglobulin and biologics convene in Las Vegas for the 15th National Conference of IgNS, focusing on advancing therapies and treatments.
The Immunoglobulin National Society (IgNS) is holding its 15th National Conference this week in Las Vegas, drawing over 1,500 attendees from more than 500 companies. The event, hosted at the Red Rock Casino Resort & Spa from October 15–18, is dedicated to four days of education, collaboration, and networking aimed at advancing immunoglobulin (Ig) and biologic therapies.
The conference program features over 50 clinical and business sessions, offering more than 30 continuing education units. Discussions will cover the clinical, operational, business, and regulatory issues shaping the field as new therapies emerge, care settings evolve, and industry challenges grow.
Luba Sobolevsky, President and CEO of IgNS, highlighted the conference as a significant milestone. "We celebrate that progress and look ahead, bringing leaders from across the Ig and biologics industry together to address shared challenges, advance clinical and operational excellence, and help shape the future of the field," she stated.
IgNS focuses on advancing immunoglobulin therapy and biologics across all sites of care. The organization provides standards, education, and resources for healthcare professionals and patients, representing over 40,000 professionals and 9,000 patients in the health and industry sectors.